National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 14467 [2018-06843]
Download as PDF
Federal Register / Vol. 83, No. 65 / Wednesday, April 4, 2018 / Notices
9609 Medical Center Drive, Room 3W110,
Rockville, MD 20850, (240) 276–5683,
toby.hecht2@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 29, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Thomas F. Conway, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G51, National Institutes of Health,
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, 240–507–9685,
thomas.conway@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
[FR Doc. 2018–06771 Filed 4–3–18; 8:45 am]
Dated: March 30, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2018–06843 Filed 4–3–18; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
amozie on DSK30RV082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Detection of HIV for SelfTesting (R61/R33).
Date: May 1–2, 2018.
Time: 10:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Roberta Binder, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G21A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, (240) 669–5050,
rbinder@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Planning Grants (R34).
Date: May 1, 2018.
Time: 1:00 p.m. to 5:00 p.m.
VerDate Sep<11>2014
18:12 Apr 03, 2018
Jkt 244001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Omics &
Spatial Interrogation of Alzheimer’s Disease.
Date: May 8, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, Suite 2W200, 7201
Wisconsin Avenue, Bethesda, MD 20892.
Contact Person: Nijaguna Prasad, Ph.D.,
Scientific Review Branch, National Institute
of Aging, National Institutes of Health, Suite
2W200, Bethesda, Md 20892, 301–496–9667,
nijaguna.prasad@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
14467
Dated: March 30, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–06841 Filed 4–3–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2010–0164]
National Boating Safety Advisory
Council
U.S. Coast Guard, Department
of Homeland Security.
ACTION: Notice of Federal Advisory
Committee Meeting.
AGENCY:
The National Boating Safety
Advisory Council and its
Subcommittees will meet to discuss
issues relating to recreational boating
safety. These meetings will be open to
the public.
DATES: Meetings: The National Boating
Safety Advisory Council will meet on
Tuesday, May 8, 2018, from 12:30 p.m.
to 6:00 p.m. and on Thursday, May 10,
2018 from 8:30 a.m. to 11:30 a.m. The
Boats and Associated Equipment
Subcommittee will meet on Wednesday,
May 9, 2018, from 8:30 a.m. to 10:30
a.m. The Prevention through People
Subcommittee will meet on Wednesday,
May 9, 2018, from 10:45 a.m. to 2:15
p.m. The Recreational Boating Safety
Strategic Planning Subcommittee will
meet on Wednesday, May 9, 2018, from
2:30 p.m. to 5:00 p.m. Please note that
these meetings may conclude early if
the National Boating Safety Advisory
Council has completed all business.
Comments and supporting
documents: To ensure your comments
are received by Council members before
the meetings, submit your written
comments no later than April 30, 2018.
Written comments must be submitted
using Federal eRulemaking Portal at
https://www.regulations.gov. If you
encounter technical difficulties with
comments submission, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section below.
ADDRESSES: All meetings will be held in
Portland, Oregon at the Broadway Room
of the Hilton Portland Downtown, 921
SW Sixth Avenue, Portland, OR 97204.
https://www3.hilton.com/en/hotels/
oregon/hilton-portland-downtownPDXPHHH/.
For information on facilities or
services for individuals with disabilities
or to request special assistance at the
SUMMARY:
E:\FR\FM\04APN1.SGM
04APN1
Agencies
[Federal Register Volume 83, Number 65 (Wednesday, April 4, 2018)]
[Notices]
[Page 14467]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-06843]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Detection of HIV for Self-Testing
(R61/R33).
Date: May 1-2, 2018.
Time: 10:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Roberta Binder, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, Room 3G21A, National Institutes of Health/NIAID, 5601
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, (240) 669-5050,
[email protected].
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Clinical Trial Planning
Grants (R34).
Date: May 1, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Thomas F. Conway, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, Room 3G51, National Institutes of Health, NIAID, 5601
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, 240-507-9685,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: March 30, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-06843 Filed 4-3-18; 8:45 am]
BILLING CODE 4140-01-P